Abstract
Cardiovascular diseases (CVD) represent a formidable global health challenge, claiming 17.6 million lives in 2016 alone, marking a 14.5% increase from 2006 to 2016. Alarmingly, mortality and morbidity rates continue to escalate, particularly in developing regions, where approximately 80% of CVD-related deaths occur, often at younger ages compared to high-income countries. Rapid economic transitions in these regions have spurred environmental shifts and unhealthy lifestyle patterns, exacerbating cardiovascular risk factors and the incidence of CVD. With population aging further compounding these challenges, the burden of CVD on individuals and societies is profound. Addressing this crisis necessitates innovative strategies for diagnosis and treatment, with artificial intelligence (AI) emerging as a potential solution. However, despite over sixty years since the inception of AI, its precise role in medicine remains nebulous. Questions persist regarding its impact on healthcare employment